© 2020 MJH Life Sciences™ and Cancer Network. All rights reserved.
Audrey Sternberg | Authors
Articles
Niraparib-Bevacizumab Combo Improves Clinical Outcomes in Recurrent Ovarian Cancer
June 05, 2020
The combination use of niraparib plus bevacizumab significantly improved clinical outcomes, compared with niraparib alone, in patients with recurrent ovarian cancer.
Promising Responses from Dual-Targeting CAR T-Cell Therapy in Myeloma Support Further Exploration
December 07, 2019
Chimeric antigen receptor T-cell therapy targeting both BCMA and CD38 induced an objective response in >90% of patients with multiple myeloma who had been treated with at least 3 prior therapies and whose disease had spread outside of the bone marrow.